| Literature DB >> 34588818 |
Ghada H Naguib1,2, Gamal S Abd El-Aziz3, Hisham A Mously4, Wafaa A Alhazmi5, Abeer M Alnowaiser6, Ali H Hassan7, Mohamed T Hamed4,8.
Abstract
PURPOSE: This in vitro study was undertaken to investigate the antimicrobial effect of distinctive oral mouth washes after the addition of zein-coated (Magnesium oxide) MgO nanoparticles on exemplary of some oral microorganisms.Entities:
Keywords: MgO; antibacterial; mouthwash; nanoparticles; zein polymer
Year: 2021 PMID: 34588818 PMCID: PMC8473931 DOI: 10.2147/CCIDE.S327912
Source DB: PubMed Journal: Clin Cosmet Investig Dent ISSN: 1179-1357
Figure 1Diameter of inhibition zones (in mm) for Oral B, Listerine Zero and Listerine Total Control with and without zein coated MgO nanoparticles with S. mutans. *Significance at p<0.05.
Means (mm) and Standard Deviations of Inhibition Zones of Different Microorganisms Around Different Mouth Washes Mixed with Different Magnesium Oxide (MgO) Nanoparticles Concentrations
| Microorganism | Mouth Wash | Inhibition Zone (mm) at MgO Concentration | p-value | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 0.30% | 0.50% | 1.00% | 2% | 5% | 10% | |||||||||
| MgOZ | MgO | MgOZ | MgO | MgOZ | MgO | MgOZ | MgO | MgOZ | MgO | MgOZ | MgO | ||||
| 12 (1.4) | 27 (0) | 9.5 (0.7) | 24.5 (0.7) | 8.5 (0.7) | 33 (0) | 10 (0) | 25 (0) | 9 (0) | 23.5 (0.7) | 10.5 (0.7) | 25 (1.4) | 13.5 (0.7) | 0.0001* | ||
| 12.5(0.7) | 28(0) | 10(0) | 27.5(0.7) | 9.5(0.7) | 29 (1.4) | 9 (1.4) | 27 (1.4) | 8 (1.4) | 27.5 (2.1) | 15 (1.4) | 25.5 (0.7) | 9.5 (0.7) | 0.0001* | ||
| 14 (2.8) | 25.5 (2.1) | 8 (0) | 27.5 (0.7) | 7 (0) | 37 (7) | 8 (0) | 35.5 (2.1) | 10 (1.4) | 25 (2.8) | 13.5 (0.7) | 24.5 (0.7) | 13.5 (0.7) | 0.0001* | ||
| 18 (0) | 26 (0) | 0 (0) | 27.5 (3.5) | 0(0) | 29 (1.4) | 0 (0) | 25.5 (0.7) | 0 (0) | 26.5 (0.7) | 8 (0) | 27 (0) | 8 (0) | 0.0001* | ||
| 0 (0) | 28.5 (2.1) | 0 (0) | 26.5 (0.7) | 0 (0) | 30.5 (0.7) | 0 (0) | 29 (2.8) | 0 (0) | 29.5 (0.7) | 7.5 (0.7) | 28 (0) | 0 (0) | 0.0001* | ||
| 13 (1.4) | 26 (1.4) | 11.5 (0.7) | 23.5 (0.7) | 10.5 (0.7) | 27.5 (0.7) | 11.5 (0.7) | 25.5 (0.7) | 13.5 (0.7) | 27 (1.4) | 11.5 (0.7) | 26.5 (0.7) | 11 (0) | 0.0001* | ||
| 7.5 (0.7) | 19.5 (2.1) | 8.5 (0.7) | 20.5 (3.5) | 8.5 (0.7) | 28 (2.8) | 8.5 (0.7) | 21 (2.8) | 9.5 (0.7) | 23.5 (0.7) | 9.5 (0.7) | 22 (0) | 0 (0) | 0.0001* | ||
| 8 (0) | 22 (1.4) | 8.5 (0.7) | 20.5 (0.7) | 7.5 (0.7) | 22.5 (0.7) | 7.5 (0.7) | 23 (1.4) | 0 (0) | 25 (1.4) | 0 (0) | 23 (0) | 0 (0) | 0.0001* | ||
| 10.5 (0.7) | 19.5 (0.7) | 12.5 (0.7) | 18.5 (0.7) | 12.5 (2.1) | 20.5 (0.7) | 11.5 (0.7) | 20.5 (0.7) | 11.5 (0.7) | 22 (0) | 11 (0) | 22 (0) | 11 (0) | 0.0001* | ||
| 7.5 (0.7) | 12.5 (0.7) | 7.5 (0.7) | 13.5 (0.7) | 8 (0) | 15.5 (2.1) | 10 (1.4) | 11.5 (0.7) | 9.5 (0.7) | 13 (0) | 16 (0) | 12.5 (0.7) | 13.5 (0.7) | 0.0001* | ||
| 7 (0) | 19.5 (6.3) | 10 (1.4) | 20 (2.8) | 8.5 (0.7) | 15 (1.4) | 15 (4.2) | 13.5 (2.1) | 10.5 (0.7) | 10.5 (0.7) | 13.5 (0.7) | 11.5 (0.7) | 11.5 (0.7) | 0.02* | ||
| 9 (1.4) | 16 (1.4) | 9.5 (0.7) | 16 (1.4) | 8.5 (0.7) | 17 (0) | 10.5 (0.7) | 19.5 (0.7) | 14 (1.4) | 19 (1.4) | 11 (0) | 19 (0) | 11 (1.4) | 0.0001* | ||
Notes: *Means Significance p-value <0.05.
Abbreviations: LT, Listerine Total; LZ, Listerine Zero; OB, Oral B.
Figure 2Diameter of inhibition zones (in mm) for Oral B, Listerine Zero and Listerine Total Control with and without zein coated MgO nanoparticles with S. aureus. *Significance at p<0.05.
Figure 3Diameter of inhibition zones (in mm) for Oral B, Listerine Zero and Listerine Total Control with and without zein coated MgO nanoparticles with E. faecalis. *Significance at p<0.05.
Figure 4Diameter of inhibition zones (in mm) for Oral B, Listerine Zero and Listerine Total Control with and without zein coated MgO nanoparticles with C. albicans. *Significance at p<0.05.